**Core Concept**
Smoldering myeloma, also known as asymptomatic myeloma, is a pre-malignant condition characterized by the presence of monoclonal plasma cells in the bone marrow and/or serum monoclonal protein, but without the presence of end-organ damage or symptoms typical of multiple myeloma.

**Why the Correct Answer is Right**
Smoldering myeloma is a critical condition to identify early, as it can progress to multiple myeloma, a life-threatening disease. The monoclonal plasma cells in this condition produce a monoclonal protein, which can be detected through serum protein electrophoresis (SPEP) or urine protein electrophoresis (UPEP). The bone marrow biopsy in smoldering myeloma typically shows 60% or more plasma cells, but the patients remain asymptomatic. The progression of smoldering myeloma to multiple myeloma is often triggered by genetic mutations that lead to the malignant transformation of plasma cells.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because smoldering myeloma is characterized by the absence of end-organ damage, which is a hallmark of multiple myeloma.
**Option B:** This option is incorrect because smoldering myeloma does not typically present with symptoms such as bone pain, anemia, or renal failure, which are common in multiple myeloma.
**Option C:** This option is incorrect because the diagnosis of smoldering myeloma is based on the presence of monoclonal plasma cells in the bone marrow and/or monoclonal protein in the serum, not on the presence of lytic lesions.

**Clinical Pearl / High-Yield Fact**
It is essential to distinguish smoldering myeloma from multiple myeloma, as the treatment approach and prognosis differ significantly between the two conditions. Early identification and monitoring of smoldering myeloma can help prevent the progression to multiple myeloma.

**Correct Answer:** D.